Article: Industry Voices – Whole-genome sequencing ultimately benefits payers

When solving a problem, taking a step back and looking at the big picture is often a wise tactic. In the context of diagnosing patients with inherited disorders, looking at the big picture can be essential for identifying the underlying cause. Genetic testing based on whole-genome sequencing (WGS) does exactly that.

Read More

News: Variantyx Launches Its WGS-Based Prenatal Test for High-Risk Pregnancies, Enters Women’s Health Market

Variantyx, a leader in high complexity hereditary disease testing, announced today that it will launch its Genomic Unity® Prenatal Analysis test at the Society for Maternal Fetal Medicine’s 41st Annual Pregnancy Meeting being held virtually January 25-30 …

Read More

Events: SMFM’s 41st Annual Pregnancy Meeting

Join us at the Society for Maternal Fetal Medicine’s virtual conference!

Read More

Variantyx Inc.

1671 Worcester Road, Suite 300
Framingham MA 01701 USA

Phone: +1 617-209-2090

  • This site is protected by reCAPTCHA and the Google Privacy and Terms of Service apply

Please do not submit Protected Health Information (PHI) through this email address.

If you need to submit Protected Health Information (PHI), please call us at 617-209-2090 and we will work with you to submit the information through an alternate mechanism.

Otherwise, please continue: